Overseas Investment News- China Business Network

Home > Overseas Investment News

Overseas Investment News

2021-07-12QNB expands its footprint in Asia with Hong Kong branch opening
2021-07-12Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI323 (Anti-LAG-3/PD-L1 Bispecific Antibody) in Patients with Advanced Malignant Tumors
2021-07-09Senmiao Technology Reports Fiscal 2021 Year-end Financial Results
2021-07-09Innovent Announces NMPA Acceptance of New Drug Application for the FGFR1/2/3 Inhibitor (Pemigatinib) for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
2021-07-08Yushangmei seeks to establish partnership with a new target company
2021-07-07MingZhu Logistics Enters into Non-binding MOU to Acquire CheYi Network
2021-07-07China Customer Relations Centers, Inc. Announces Completion of Merger
2021-07-06Innovent and Laekna Therapeutics Enter a Partnership Agreement to Co-Develop Combination Therapy of Sintilimab and Afuresertib in Clinical Studies in China
2021-07-06TD Holdings, Inc. Enters into Strategic Alliance Framework Agreement to Exploit Global Mineral Resources
2021-07-05Suning's rural retailer Retail Cloud will open 900 new stores in Q3
2021-07-02TD Holdings, Inc. Regains Compliance with Nasdaq's Listing Requirements
2021-07-02Telling Hainan's history for 100 years with 22 meters of heritage
2021-07-01New-Generation Intelligent Pickup Truck, GWM POER Wins Praise from Media
2021-07-01Dogness Adds Three New Distributors to Meet Growth
2021-07-01Daqo New Energy Issues Its First Environmental, Social and Governance (ESG) Report
2021-06-30Senmiao Technology to Report Fiscal 2021 Year-end Financial Results by July 9, 2021
2021-06-30Puhui Wealth Investment Management Co. Ltd. Announces Financial Results for the Six Months Ended December 31, 2020
2021-06-29MingZhu Logistics Announces Audited Full Year 2020 Financial Results
2021-06-29Innovent Announces License Agreement with Synaffix in an ADC Technology Deal
2021-06-28Innovent Announces the China NMPA Approval of TYVYT? (sintilimab injection) in Combination with BYVASDA? (bevacizumab biosimilar injection) as First-Line Therapy for People with Hepatocellular Carcinoma

First　Previous　134 135 136 137 138　Next　Last　Total 5131 20/Page Page 135 of 257 Go To: